Dr. Natraj R Ammakkanavar
Claim this profileCommunity Health Network
Studies Non-Small Cell Lung Cancer
Studies Cancer
4 reported clinical trials
8 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
KRAS positive
Stage III
Stage IV
2Cancer
Stage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials Natraj R Ammakkanavar is currently running
LY3537982 + Immunotherapy/Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing a new drug, LY3537982, combined with standard treatments for patients with advanced lung cancer that have a specific genetic mutation. The goal is to see if this combination works better than the usual treatments alone.
Recruiting1 award Phase 314 criteria
SKB264 + Pembrolizumab
for Solid Tumors
The purpose of this study is to evaluate the efficacy and safety of combination of SKB264 and Pembrolizumab in patients with selected solid tumors including cervical cancer, urothelial cancer, ovarian cancer, prostate cancer,advanced endometrial cancer.
Recruiting1 award Phase 24 criteria
More about Natraj R Ammakkanavar
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Natraj R Ammakkanavar has experience with
- Pembrolizumab
- Carboplatin
- Pemetrexed
- SEA-CD40
- Cisplatin
- LY3537982
Breakdown of trials Natraj R Ammakkanavar has run
Non-Small Cell Lung Cancer
Cancer
Solid Tumors
Gastroesophageal Junction Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Natraj R Ammakkanavar specialize in?
Natraj R Ammakkanavar focuses on Non-Small Cell Lung Cancer and Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved KRAS positive patients, or patients who are Stage III.
Is Natraj R Ammakkanavar currently recruiting for clinical trials?
Yes, Natraj R Ammakkanavar is currently recruiting for 3 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Natraj R Ammakkanavar has studied deeply?
Yes, Natraj R Ammakkanavar has studied treatments such as Pembrolizumab, Carboplatin, Pemetrexed.
What is the best way to schedule an appointment with Natraj R Ammakkanavar?
Apply for one of the trials that Natraj R Ammakkanavar is conducting.
What is the office address of Natraj R Ammakkanavar?
The office of Natraj R Ammakkanavar is located at: Community Health Network, Indianapolis, Indiana 46250 United States. This is the address for their practice at the Community Health Network.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.